Literature DB >> 26786650

Identification of novel loci associated with mycobacterial isoniazid resistance.

Gopinath Viswanathan1, Sangya Yadav1, Tirumalai R Raghunand2.   

Abstract

Despite the known association of several genes to clinical Isoniazid (INH) resistance, its molecular basis remains unknown in ~16% of clinical isolates of Mycobacterium tuberculosis (M. tb). While screening a set of Mycobacterium smegmatis (M. smegmatis) transposon mutants with altered colony morphology for differential susceptibility to INH, we found six resistant mutants and mapped their transposon insertion sites. The disrupted genes in six INH resistant mutants were homologs of M. tb ctaE, rplY, tatA, csd and tatB with one insertion mapping to the promoter region of M. smegmatis ctaE. MIC measurements indicated a wide spectrum of INH resistance in these mutants, with complementation analyses of four selected mutants with the cognate M. smegmatis genes and their M. tb homologs confirming the association of the disrupted genes with INH resistance. Our discovery of novel genes associated with INH resistance could lead to the identification of novel INH resistance mechanisms and possibly new diagnostic modalities as well.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug resistance; Isoniazid; Mycobacterium smegmatis; Mycobacterium tuberculosis; Resazurin; Transposon mutagenesis

Mesh:

Substances:

Year:  2015        PMID: 26786650     DOI: 10.1016/j.tube.2015.09.008

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  2 in total

1.  Activation of the SigE-SigB signaling pathway by inhibition of the respiratory electron transport chain and its effect on rifampicin resistance in Mycobacterium smegmatis.

Authors:  Yuna Oh; Hye-In Lee; Ji-A Jeong; Seonghan Kim; Jeong-Il Oh
Journal:  J Microbiol       Date:  2022-08-01       Impact factor: 2.902

2.  Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.

Authors:  Gopinath Viswanathan; Sangya Yadav; Tirumalai R Raghunand
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.